New HIV drug can only offer hope of ending AIDS if all have …
GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
FDA Approves Cabenuva and Vocabria for the Treatment ...
Jan 27, 2021 · CABENUVA, a 2-drug co-packaged product of cabotegravir, a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse...
FDA Approves New HIV Drug for Adults with Limited Treatment …
Jan 4, 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
Code Pharma’s Gammora® Demonstrates Highly Favorable
1 day ago · “These incredibly positive outcomes offer new hope at a time when 40 million individuals worldwide are impacted by HIV and the current standard of care with ART drugs does not offer a cure at ...
Long-Acting Drugs May Revolutionize H.I.V. Prevention ...
Apr 17, 2024 · New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
FDA Approves New HIV Treatment for Patients With Limited …
FDA approved Rukobia (fostemsavir), a new antiretroviral medication for adult patients with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated...
FDA Approves First Extended-Release, Injectable Drug Regimen …
Jan 21, 2021 · The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type...
Lenacapavir: Drug Offers New Hope for Multi-drug Resistant HIV
Aug 30, 2023 · Lenacapavir is a new FDA-approved HIV injection that is safe, highly effective, and taken only twice per year. Its approval was based on work led by Onyema.
FDA approves first-in-class HIV capsid inhibitor - Nature
Jan 10, 2023 · The FDA has approved Gilead Science’s first-in-class capsid inhibitor lenacapavir, providing a new treatment option for people with multidrug-resistant HIV.
FDA Approves First Extended-Release, Injectable Drug Regimen ... - HIV…
Jan 22, 2021 · [Yesterday] the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral ...